The management of non-small cell lung cancer has undergone major transformation in the last three years driven by the increasing using of immunotherapy as well as local ablative therapies in advanced stage disease.  Translation of these practices into community based setting is important as overa

IJROBP Journal SA-CME activity for August 1, 2021 provides practitioners with knowledge about how the increases in germline testing have led to an increase in the identification of ATM carriers in the breast cancer population and how the implications for radiation therapy treatment in this popula

Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.

Endometrial Cancer